Geode Capital Management’s Cryo-Cell International CCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding CCEL
SA
MPWT
Geode Capital Management's CCEL Position: Q2 2026 in Review
Geode Capital Management increased its Cryo-Cell International (CCEL) stake by 6.1% in Q2 2026, buying an estimated $9.46K and bringing the position to 46,273 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4008.
Geode Capital Management first reported a position in CCEL in Q3 2022 and has held it in 16 quarters since. The position peaked at $295K in Q4 2024. 12 funds tracked by Wall St. Rank hold CCEL as of Q2 2026.
- Geode Capital Management held 46,273 shares of Cryo-Cell International worth $148K as of Q2 2026.
- Geode Capital Management bought 2,657 Cryo-Cell International shares in Q2 2026, an estimated $9.46K.
- Cryo-Cell International made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4008 holding.
- Geode Capital Management first reported a position in Cryo-Cell International in Q3 2022 and has held it in 16 quarters since.
- Geode Capital Management's Cryo-Cell International position peaked at $295K in Q4 2024.
- 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.